In a new study published online today in The Journal of Neuroscience, researchers found that chronic administration of estradiol boosts cognitive performance in aged female rhesus monkeys.

A drug that blocks the chemical messengers that are overactive in allergic reactions proved effective in clearing or reducing symptoms caused by atopic eczema, based on results from an international Phase III clinical trial led by OHSU in Portland, Oregon.

A breakthrough study published online this week in the journal Nucleic Acids Research suggests that it may be possible to treat genetic disease detected in the womb by safely and efficiently delivering gene-altering therapies through a kind of reverse amniocentesis.

New research reveals for the first time the atomic structures of a key molecular receptor in the brain, which opens the door for developing medications that could block activation of these receptors to address a variety of conditions, ranging from pain to high blood pressure to early formation of blood clots.

Restoring tumor-specific immunity is a treatment strategy that works well in melanoma and lung cancer patients.

A new study led by nationally prominent stem cell scientist Markus Grompe, M.D., has determined the existence of at least four separate subtypes of human insulin producing beta cells that may be important in the understanding and treatment of ...

A first-of-its-kind controlled clinical trial found that a low-fat, plant-based diet significantly improved the health of people with multiple sclerosis by reducing both fatigue and weight. Those improvements go hand-in-hand with fighting some of the most debilitating effects of MS.

With $42 million in funding from the National Institutes of Health, scientists from Beth Israel Deaconess Medical Center (BIDMC) and Oregon Health &Science University (OHSU) will lead a five-year research initiative to advance efforts to cure and ...